Join us on the latest episode! Our Guest: Pascal Touchon, President and CEO at Atara BiotherapeuticsWhat you'll get out of this episode:- Backstory on Pascal- Leading CAR-T at Novartis and Atara, focusing on lymphoma.- Creation of EBV T Cell Platform for cancer and autoimmune diseases.- The milestones for Ebalo, including European approval.- Impacting cell therapy with validation, quality manufacturing.- Planned future directions, including FDA alignment and partnerships.To learn more about Atara Biotherapeutics: https://www.atarabio.com/Our sponsors for this episode are:Sage Growth Partners https://sage-growth.com/FlipMD by GoodRX https://www.goodrx.com/Quantum Health https://quantum-health.com/

Ver todos los episodios